
Airway Management Devices Market (Product Type: Supraglottic Device, Infraglottic Device, Resuscitators, and Laryngoscope; Patient Age: Adult and Pediatric) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
Description
Airway Management Devices Market (Product Type: Supraglottic Device, Infraglottic Device, Resuscitators, and Laryngoscope; Patient Age: Adult and Pediatric) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
Companies Mentioned
Evonik Industries AG
Huntsman International LLC.
INEOS Group Holdings S.A.
Solutia Inc.
Arkema S.A.
Celanese Corporation
Bayer AG
DIC Corporation
DowDuPont Inc
Royal DSM N.V.
LANXESS
BASF SE.
Allnex Holdings S.à r.l.
Countries
North America
Europe
Asia Pacific
Middle East & Africa
Latin America
Forecast Year (first) - 2022
Forecast Year (last) - 2031
Forecast Year ( first) Value - 1.1
Forecast Year (last) Value - 2.3
CAGR % - 0.077
Currency - US$ Bn
Companies Mentioned
Evonik Industries AG
Huntsman International LLC.
INEOS Group Holdings S.A.
Solutia Inc.
Arkema S.A.
Celanese Corporation
Bayer AG
DIC Corporation
DowDuPont Inc
Royal DSM N.V.
LANXESS
BASF SE.
Allnex Holdings S.à r.l.
Countries
North America
Europe
Asia Pacific
Middle East & Africa
Latin America
Forecast Year (first) - 2022
Forecast Year (last) - 2031
Forecast Year ( first) Value - 1.1
Forecast Year (last) Value - 2.3
CAGR % - 0.077
Currency - US$ Bn
Table of Contents
157 Pages
- 1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
- 2. Assumptions and Research Methodology
- 3. Executive Summary: Global Airway Management Devices Market
- 4. Market Overview
- 4.1. Introduction
- 4.1.1. Product Type Definition
- 4.1.2. Industry Evolution / Developments
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Airway Management Devices Market Analysis and Forecast, 2017–2031
- 4.4.1. Market Revenue Projections (US$ Bn)
- 5. Key Insights
- 5.1. Increase in prevalence of respiratory diseases
- 5.2. Technological advancements
- 5.3. Key Industry Events
- 5.4. COVID-19 Impact
- 6. Global Airway Management Devices Market Analysis and Forecast, by Product Type
- 6.1. Introduction & Definition
- 6.2. Key Findings / Developments
- 6.3. Market Value Forecast, by Product Type, 2017–2031
- 6.3.1. Supraglottic Device
- 6.3.2. Infraglottic Device
- 6.3.3. Resuscitators
- 6.3.4. Laryngoscope
- 6.4. Market Attractiveness Analysis, by Product Type
- 7. Global Airway Management Devices Market Analysis and Forecast, by End-user
- 7.1. Introduction & Definition
- 7.2. Key Findings / Developments
- 7.3. Market Value Forecast, by End-user, 2017–2031
- 7.3.1. Operating Room (OR)
- 7.3.2. Intensive Care Unit (ICU)
- 7.3.3. Others
- 7.4. Market Attractiveness Analysis, by End-user
- 8. Global Airway Management Devices Market Analysis and Forecast, by Patient Age
- 8.1. Introduction & Definition
- 8.2. Key Findings / Developments
- 8.3. Market Value Forecast, by Patient Age, 2017–2031
- 8.3.1. Adult
- 8.3.2. Pediatric
- 8.4. Market Attractiveness Analysis, by Patient Age
- 9. Global Airway Management Devices Market Analysis and Forecast, by Region
- 9.1. Key Findings
- 9.2. Market Value Forecast, by Region
- 9.2.1. North America
- 9.2.2. Europe
- 9.2.3. Asia Pacific
- 9.2.4. Latin America
- 9.2.5. Middle East & Africa
- 9.3. Market Attractiveness Analysis, by Region
- 10. North America Airway Management Devices Market Analysis and Forecast
- 10.1. Introduction
- 10.1.1. Key Findings
- 10.2. Market Value Forecast, by Product Type, 2017–2031
- 10.2.1. Supraglottic Device
- 10.2.2. Infraglottic Device
- 10.2.3. Resuscitators
- 10.2.4. Laryngoscope
- 10.3. Market Value Forecast, by End-user, 2017–2031
- 10.3.1. Operating Room (OR)
- 10.3.2. Intensive Care Unit (ICU)
- 10.3.3. Others
- 10.4. Market Value Forecast, by Patient Age, 2017–2031
- 10.4.1. Adult
- 10.4.2. Pediatric
- 10.5. Market Value Forecast, by Country, 2017–2031
- 10.5.1. U.S.
- 10.5.2. Canada
- 10.6. Market Attractiveness Analysis
- 10.6.1. by Product Type
- 10.6.2. by End-user
- 10.6.3. by Patient Age
- 10.6.4. by Country
- 11. Europe Airway Management Devices Market Analysis and Forecast
- 11.1. Introduction
- 11.1.1. Key Findings
- 11.2. Market Value Forecast, by Product Type, 2017–2031
- 11.2.1. Supraglottic Device
- 11.2.2. Infraglottic Device
- 11.2.3. Resuscitators
- 11.2.4. Laryngoscope
- 11.3. Market Value Forecast, by End-user, 2017–2031
- 11.3.1. Operating Room (OR)
- 11.3.2. Intensive Care Unit (ICU)
- 11.3.3. Others
- 11.4. Market Value Forecast, by Patient Age, 2017–2031
- 11.4.1. Adult
- 11.4.2. Pediatric
- 11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
- 11.5.1. Germany
- 11.5.2. U.K.
- 11.5.3. France
- 11.5.4. Spain
- 11.5.5. Italy
- 11.5.6. Rest of Europe
- 11.6. Market Attractiveness Analysis
- 11.6.1. by Product Type
- 11.6.2. by End-user
- 11.6.3. by Patient Age
- 11.6.4. by Country/Sub-region
- 12. Asia Pacific Airway Management Devices Market Analysis and Forecast
- 12.1. Introduction
- 12.1.1. Key Findings
- 12.2. Market Value Forecast, by Product Type, 2017–2031
- 12.2.1. Supraglottic Device
- 12.2.2. Infraglottic Device
- 12.2.3. Resuscitators
- 12.2.4. Laryngoscope
- 12.3. Market Value Forecast, by End-user, 2017–2031
- 12.3.1. Operating Room (OR)
- 12.3.2. Intensive Care Unit (ICU)
- 12.3.3. Others
- 12.4. Market Value Forecast, by Patient Age, 2017–2031
- 12.4.1. Adult
- 12.4.2. Pediatric
- 12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
- 12.5.1. China
- 12.5.2. Japan
- 12.5.3. India
- 12.5.4. Australia & New Zealand
- 12.5.5. Rest of Asia Pacific
- 12.6. Market Attractiveness Analysis
- 12.6.1. by Product Type
- 12.6.2. by End-user
- 12.6.3. by Patient Age
- 12.6.4. by Country/Sub-region
- 13. Latin America Airway Management Devices Market Analysis and Forecast
- 13.1. Introduction
- 13.1.1. Key Findings
- 13.2. Market Value Forecast, by Product Type, 2017–2031
- 13.2.1. Supraglottic Device
- 13.2.2. Infraglottic Device
- 13.2.3. Resuscitators
- 13.2.4. Laryngoscope
- 13.3. Market Value Forecast, by End-user, 2017–2031
- 13.3.1. Operating Room (OR)
- 13.3.2. Intensive Care Unit ICU
- 13.3.3. Others
- 13.4. Market Value Forecast, by Patient Age, 2017–2031
- 13.4.1. Adult
- 13.4.2. Pediatric
- 13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
- 13.5.1. Brazil
- 13.5.2. Mexico
- 13.5.3. Rest of Latin America
- 13.6. Market Attractiveness Analysis
- 13.6.1. by Product Type
- 13.6.2. by End-user
- 13.6.3. by Patient Age
- 13.6.4. by Country/Sub-region
- 14. Middle East & Africa Airway Management Devices Market Analysis and Forecast
- 14.1. Introduction
- 14.1.1. Key Findings
- 14.2. Market Value Forecast, by Product Type, 2017–2031
- 14.2.1. Supraglottic Device
- 14.2.2. Infraglottic Device
- 14.2.3. Resuscitators
- 14.2.4. Laryngoscope
- 14.3. Market Value Forecast, by End-user, 2017–2031
- 14.3.1. Operating Room(OR)
- 14.3.2. Intensive Care Unit (ICU)
- 14.3.3. Others
- 14.4. Market Value Forecast, by Patient Age, 2017–2031
- 14.4.1. Adult
- 14.4.2. Pediatric
- 14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
- 14.5.1. GCC Countries
- 14.5.2. South Africa
- 14.5.3. Rest of Middle East & Africa
- 14.6. Market Attractiveness Analysis
- 14.6.1. by Product Type
- 14.6.2. by End-user
- 14.6.3. by Patient Age
- 14.6.4. by Country/Sub-region
- 15. Competition Landscape
- 15.1. Market Player - Competition Matrix (by tier and size of companies)
- 15.2. Market Share Analysis, by Company, 2021
- 15.3. Company Profiles
- 15.3.1. Ambu A/S
- 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.1.2. Product Portfolio
- 15.3.1.3. SWOT Analysis
- 15.3.1.4. Strategic Overview
- 15.3.2. GE Healthcare
- 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.2.2. Product Portfolio
- 15.3.2.3. SWOT Analysis
- 15.3.2.4. Strategic Overview
- 15.3.3. Karl Storz GmbH & Co. KG
- 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.3.2. Product Portfolio
- 15.3.3.3. SWOT Analysis
- 15.3.3.4. Strategic Overview
- 15.3.4. Koninklijke Philips N.V.
- 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.4.2. Product Portfolio
- 15.3.4.3. SWOT Analysis
- 15.3.4.4. Strategic Overview
- 15.3.5. Medtronic plc
- 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.5.2. Product Portfolio
- 15.3.5.3. SWOT Analysis
- 15.3.5.4. Strategic Overview
- 15.3.6. Medline Industries, Inc.
- 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.6.2. Product Portfolio
- 15.3.6.3. SWOT Analysis
- 15.3.6.4. Strategic Overview
- 15.3.7. Olympus Corporation
- 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.7.2. Product Portfolio
- 15.3.7.3. SWOT Analysis
- 15.3.7.4. Strategic Overview
- 15.3.8. Smiths Medical
- 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.8.2. Product Portfolio
- 15.3.8.3. SWOT Analysis
- 15.3.8.4. Strategic Overview
- 15.3.9. Teleflex Incorporated
- 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.9.2. Product Portfolio
- 15.3.9.3. SWOT Analysis
- 15.3.9.4. Strategic Overview
- 15.3.10. VYAIRE
- 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.10.2. Product Portfolio
- 15.3.10.3. SWOT Analysis
- 15.3.10.4. Strategic Overview
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.